QRG CAPITAL MANAGEMENT, INC.

Position in VTRS — Viatris Inc

CIK 1996454 BERWYN, PA

Position in VTRS

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$787,076

+$199,500 QoQ

Shares Held

49,564

+14.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#23

of 123 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $23,691,979 across 10 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	372,752	$5,975,214
2	ZTS	Zoetis Inc.	54,575	$3,921,759
3	HLN	Haleon plc	383,552	$3,578,540
4	NBIX	Neurocrine Biosciences Inc	18,903	$3,185,911
5	TEVA	Teva Pharmaceutical Industries Ltd	89,078	$3,017,962
6	UTHR	UNITED THERAPEUTICS Corp	3,476	$1,883,401
7	VTRS	Viatris Inc This page	49,564	$787,076
8	RDY	Dr Reddys Laboratories Ltd	41,233	$597,466

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$787,076	49,564	+14.0%	Shares	Sole	2026-07-14
2026-03-31	$587,576	43,492	+246.7%	Shares	Sole	2026-04-27
2025-06-30	$112,026	12,545	-56.1%	Shares	Sole	2025-07-21
2025-03-31	$248,923	28,579	-64.4%	Shares	Sole	2025-04-17
2024-12-31	$998,639	80,212	-6.2%	Shares	Sole	2025-02-05
2024-09-30	$992,898	85,521	-63.7%	Shares	Sole	2024-10-30
2024-06-30	$2,501,866	235,359	-2.2%	Shares	Sole	2024-07-12
2024-03-31	$2,873,635	240,673	-7.0%	Shares	Sole	2024-05-07
2023-12-31	$2,802,089	258,734	-6.7%	Shares	Sole	2024-02-07
2023-09-30	$2,735,193	277,403	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.